Tumor organoid tech advances precision medicine cancer treatments

Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of cells that mimic structural and functional features of an organ, tumor or other tissue. The advances represent progress in precision medicine and point to the more routine use of tumor organoids as models for evaluating and optimizing cancer treatments.

Raccontata damedicalxpress.com